MAGELLAN HEALTH INC (MGLN) Stock Price, Quote, News and Overview
NASDAQ:MGLN - Nasdaq - Common Stock
MGLN Quote, Performance and Key Statistics
94.99
0 (0%)
The current stock price of MGLN is 94.99 null. In the past month the price increased by 0.58%. In the past year, price increased by 0.68%.
MGLN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 16.71 | 429.24B | ||
| ELV | ELEVANCE HEALTH INC | 11.68 | 89.31B | ||
| HUM | HUMANA INC | 15.81 | 30.87B | ||
| CNC | CENTENE CORP | 8.12 | 28.60B | ||
| MOH | MOLINA HEALTHCARE INC | 12.53 | 15.75B | ||
| HQY | HEALTHEQUITY INC | 35.37 | 9.41B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.53B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.20B | ||
| PGNY | PROGYNY INC | 40 | 1.98B | ||
| NEUE | NEUEHEALTH INC | 5.57 | 60.93M |
Related stock screener links
About MGLN
Company Profile
Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).
Company Info
MAGELLAN HEALTH INC
4801 E Washington St
Phoenix ARIZONA 85034 US
CEO: Kenneth J. Fasola
Employees: 9000
Company Website: https://www.magellanhealth.com/
Phone: 18006421716.0
MAGELLAN HEALTH INC / MGLN FAQ
What is the stock price of MAGELLAN HEALTH INC today?
The current stock price of MGLN is 94.99 null.
What is the ticker symbol for MAGELLAN HEALTH INC stock?
The exchange symbol of MAGELLAN HEALTH INC is MGLN and it is listed on the Nasdaq exchange.
On which exchange is MGLN stock listed?
MGLN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MAGELLAN HEALTH INC stock?
6 analysts have analysed MGLN and the average price target is 96.9 null. This implies a price increase of 2.01% is expected in the next year compared to the current price of 94.99. Check the MAGELLAN HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MAGELLAN HEALTH INC worth?
MAGELLAN HEALTH INC (MGLN) has a market capitalization of 2.46B null. This makes MGLN a Mid Cap stock.
How many employees does MAGELLAN HEALTH INC have?
MAGELLAN HEALTH INC (MGLN) currently has 9000 employees.
What are the support and resistance levels for MAGELLAN HEALTH INC (MGLN) stock?
MAGELLAN HEALTH INC (MGLN) has a support level at 94.8 and a resistance level at 95. Check the full technical report for a detailed analysis of MGLN support and resistance levels.
Is MAGELLAN HEALTH INC (MGLN) expected to grow?
The Revenue of MAGELLAN HEALTH INC (MGLN) is expected to grow by 8.27% in the next year. Check the estimates tab for more information on the MGLN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MAGELLAN HEALTH INC (MGLN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MGLN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MGLN, evaluating the profitability, health, valuation and growth aspects
- MAGELLAN HEALTH INC (MGLN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MAGELLAN HEALTH INC (MGLN) Sales and EPS estimates to see what analysts future expectations are.
- MAGELLAN HEALTH INC (MGLN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MAGELLAN HEALTH INC (MGLN) Insider and Institutional Ownership to learn about the owners and their transactions.
- MAGELLAN HEALTH INC (MGLN) Stock Chart to make your own analysis
- MAGELLAN HEALTH INC (MGLN) Latest news and press-releases to stay up to date.
Does MAGELLAN HEALTH INC (MGLN) stock pay dividends?
MGLN does not pay a dividend.
When does MAGELLAN HEALTH INC (MGLN) report earnings?
MAGELLAN HEALTH INC (MGLN) will report earnings on 2022-03-04, after the market close.
What is the Price/Earnings (PE) ratio of MAGELLAN HEALTH INC (MGLN)?
The PE ratio for MAGELLAN HEALTH INC (MGLN) is 87.15. This is based on the reported non-GAAP earnings per share of 1.09 and the current share price of 94.99 null. Check the full fundamental report for a full analysis of the valuation metrics for MGLN.
MGLN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to MGLN. When comparing the yearly performance of all stocks, MGLN turns out to be only a medium performer in the overall market: it outperformed 49.92% of all stocks.
MGLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MGLN. MGLN has an excellent financial health rating, but there are some minor concerns on its profitability.
MGLN Financial Highlights
Over the last trailing twelve months MGLN reported a non-GAAP Earnings per Share(EPS) of 1.09. The EPS decreased by -67.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.26% | ||
| ROA | 9% | ||
| ROE | 15.61% | ||
| Debt/Equity | 0.27 |
MGLN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to MGLN. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 11.05% and a revenue growth 8.27% for MGLN